Domingo A. Pascual Figal

Has grant

Full Professor (Catedrático)

Universidad de Murcia

Spain

Research Interests

Explore related searches

Professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Domingo A. Pascual Figal is a Full Professor at Universidad de Murcia in Spain. His primary research areas include the management of cardiovascular diseases, heart failure, and the implications of pharmacological therapies in clinical practice. He has recently published articles addressing topics such as the monetary value of a statistical life in relation to atherosclerotic cardiovascular disease and the role of colchicine in heart failure. His work also explores innovative approaches to personalized anti-inflammatory therapy and the impacts of clonal hematopoiesis on cardiac health.

Recent Grants

Grant: Close

Precision biomarkers for improved diagnosis and treatment of inflammatory myocardial disease (PreMYO)

Open Date: 2023-01-01

Close Date: 2025-01-01

Grant: Close

Somatic mutations and clonal hematopoiesis as predictors and drivers of heart failure progression. MyoClonal

Open Date: 2022-01-01

Close Date: 2025-01-01

Grant: Close

Role of somatic mutations and clonal haematopoiesis in heart failure progression

Open Date: 2021-01-01

Close Date: 2023-01-01

Grant: Close

Impact on atrial remodelling of dapagliflozin in patients with heart failure: MODA study.

Open Date: 2021-01-01

Close Date: 2023-01-01

Grant: Close

Withdrawal of pharmacological treatment in patients responding to cardiac resynchronisation therapy: A randomised open-label study (REMOVE)

Open Date: 2021-01-01

Close Date: 2024-01-01

Articles (18)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (10)

José Ramón González Juanatey

SPAIN

View details

Klaus Witte

University of Leeds

UNITED KINGDOM

View details

Miguel Camafort

University of Barcelona

SPAIN

View details

Jesús Álvarez‐García

SPAIN

View details

Fernando I. Sánchez-Martínez

Professor

Universidad de Murcia

SPAIN

View details

José Javier Fuster

Assistant Professor

Centro Nacional de Investigaciones Cardiovasculares (CNIC)

SPAIN

View details

JOSEBE GOIRIGOLZARRI ARTAZA

HEAD OF THE HEART FAILURE UNIT

Hospital Clínico San Carlos

SPAIN

View details

Javier Limeres Freire

Vall d'Hebron Institut de Recerca

SPAIN

View details

Luis Serratosa

Head of the Dpt

Hospital Universitario Quirónsalud Madrid

SPAIN

View details

Juan Francisco Delgado Jiménez

Full Professor

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Domingo A. Pascual Figal

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (18)

The Monetary Value of a Statistical Life in the Context of Atherosclerotic Cardiovascular Disease

Colchicine in acutely decompensated heart failure: the COLICA trial

Clonal haematopoiesis and cardiac arrythmias: rhythm-altering mutations

Colchicine in acute heart failure: Rationale and design of a randomized double‐blind placebo‐controlled trial (COLICA)

The Possible Synergistic Pharmacological Effect of an Oral Berberine (BBR) and Curcumin (CUR) Complementary Therapy Alleviates Symptoms of Irritable Bowel Syndrome (IBS): Results from a Real-Life, Routine Clinical Practice Settings-Based Study

N‐terminal pro‐B‐type natriuretic peptide post‐discharge monitoring in the management of patients with heart failure and preserved ejection fraction – a randomized trial: The NICE study

Impact of dapagliflozin on cardiac remodelling in patients with chronic heart failure: the <scp>DAPA‐MODA</scp> study

Influence of diabetes on sacubitril/valsartan titration and clinical outcomes in patients hospitalized for heart failure

Circulating ST2, from biomarker to pathogenic mediator

Clonal hematopoiesis is not prevalent in Hutchinson-Gilford progeria syndrome

Coronary Artery Disease and Prognosis of Heart Failure with Reduced Ejection Fraction

Impact of ferric carboxymaltose for iron deficiency at discharge after heart failure hospitalization: a European multinational economic evaluation

Impact of renal function on Ticagrelor-induced antiplatelet effects in coronary artery disease patients

Making STRONGer the Transition Phase: Personalized GDMT Through NT-proBNP monitoring

Myocarditis related SARS-CoV-2 infection or vaccination: an expert consensus statement on its diagnosis and management

Optimization of Patient Pathway in Heart Failure with Reduced Ejection Fraction and Worsening Heart Failure. Role of Vericiguat

Current Role of SLGT2 Inhibitors in the Management of the Whole Spectrum of Heart Failure: Focus on Dapagliflozin

Personalizing anti‐inflammatory therapy in heart failure: A new way

Collaborators (10)

José Ramón González Juanatey

Klaus Witte

Miguel Camafort

Jesús Álvarez‐García

Fernando I. Sánchez-Martínez

José Javier Fuster

JOSEBE GOIRIGOLZARRI ARTAZA

Javier Limeres Freire

Luis Serratosa

Juan Francisco Delgado Jiménez

Make your next move.